These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 37964390

  • 1. Efficacy of either orally administered fluralaner or topically administered imidacloprid/flumethrin for controlling Rhipicephalus sanguineus sensu lato premises infestations.
    Labruna MB, Doretto JS, de Araújo Nascimento OC, Barufi FB, Rosa SC, Osowski GV, Drake J, Armstrong R.
    Parasit Vectors; 2023 Nov 14; 16(1):414. PubMed ID: 37964390
    [Abstract] [Full Text] [Related]

  • 2. A comparative laboratory trial evaluating the immediate efficacy of fluralaner, afoxolaner, sarolaner and imidacloprid + permethrin against adult Rhipicephalus sanguineus (sensu lato) ticks attached to dogs.
    Burgio F, Meyer L, Armstrong R.
    Parasit Vectors; 2016 Dec 03; 9(1):626. PubMed ID: 27912787
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative Efficacy of an Imidacloprid/Flumethrin Collar (Seresto®) and an Oral Fluralaner Chewable Tablet (Bravecto®) against Tick (Dermacentor variabilis and Amblyomma americanum) Infestations on Dogs: a Randomised Controlled Trial.
    Ohmes CM, Hostetler J, Davis WL, Settje T, McMinn A, Everett WR.
    Parasitol Res; 2015 Aug 03; 114 Suppl 1():S95-108. PubMed ID: 26152411
    [Abstract] [Full Text] [Related]

  • 6. Year-round efficacy of a single treatment of fluralaner injectable suspension (Bravecto Quantum™) against repeated infestations with Rhipicephalus sanguineus (sensu lato) and Ctenocephalides felis in dogs.
    Fisara P, Guerino F.
    Parasit Vectors; 2023 Oct 23; 16(1):378. PubMed ID: 37872632
    [Abstract] [Full Text] [Related]

  • 7. Sustained efficacy of collars containing 10% w/w imidacloprid and 4.5% w/w flumethrin (Seresto®) in dogs against laboratory challenge with Haemaphysalis longicornis (Neumann, 1901) ticks.
    Meyer L, Lekouch N, Altreuther G, Schunack B, Pollmeier M.
    Parasit Vectors; 2022 Mar 05; 15(1):77. PubMed ID: 35248151
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of a combination of 10% imidacloprid and 4.5% flumethrin (Seresto®) in slow release collars to control ticks and fleas in highly infested dog communities.
    Brianti E, Falsone L, Napoli E, Prudente C, Gaglio G, Giannetto S.
    Parasit Vectors; 2013 Jul 18; 6():210. PubMed ID: 23866926
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and speed of kill of a topically applied formulation of dinotefuran-permethrin-pyriproxyfen against weekly tick infestations with Rhipicephalus sanguineus (sensu lato) on dogs.
    Blair J, Fourie JJ, Varloud M, Horak IG.
    Parasit Vectors; 2016 May 16; 9(1):283. PubMed ID: 27183970
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Water immersion of dogs close to the time of topical fluralaner treatment does not reduce efficacy against a subsequent experimental challenge with Rhipicephalus sanguineus (sensu lato).
    Dongus H, Meyer L, Armstrong R.
    Parasit Vectors; 2017 Sep 25; 10(1):441. PubMed ID: 28946900
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of collars with allomones on dogs to control Rhipicephalus sanguineus sensu lato infestations under field conditions.
    Barreto LP, Ribeiro-Silva CS, Machado LDC, Lima VH, Pinto SMN, Pereira-Junior RA, Carreira DN, Mascarin GM, Fernandes ÉKK, Borges LMF.
    Ticks Tick Borne Dis; 2021 Sep 25; 12(5):101769. PubMed ID: 34218055
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.